image
blog

Shutdown Woes May Also Hit Ten Months After FDA Receives Funding

The Office of Generic Drugs (OGD) has taken great pride in meeting all of its GDUFA goals (including most, if not all, ANDA review goal dates). But, Houston, we may have a problem!

Shutdown Woes May Also Hit Ten Months After FDA Receives Funding

The Office of Generic Drugs (OGD) has taken great pride in meeting all of its GDUFA goals (including most, if not all, ANDA review goal dates). But, Houston, we may have a problem!

Shutdown Woes May Also Hit Ten Months After FDA Receives Funding

The Office of Generic Drugs (OGD) has taken great pride in meeting all of its GDUFA goals (including most, if not all, ANDA review goal dates). But, Houston, we may have a problem!

Shutdown Woes May Also Hit Ten Months After FDA Receives Funding

The Office of Generic Drugs (OGD) has taken great pride in meeting all of its GDUFA goals (including most, if not all, ANDA review goal dates). But, Houston, we may have a problem!

Shutdown Woes May Also Hit Ten Months After FDA Receives Funding

The Office of Generic Drugs (OGD) has taken great pride in meeting all of its GDUFA goals (including most, if not all, ANDA review goal dates). But, Houston, we may have a problem!

MAKE AN REGISTRATION

Rockwell will provide the opportunity to registered professional first with confidential information.